chlorpromazine has been researched along with dihydrexidine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brewster, WK; Mailman, RB; Mottola, D; Nichols, DE; Riggs, RM; Watts, VJ | 1 |
| Ghosh, D; Mailman, RB; Nichols, DE; Snyder, SE; Watts, VJ | 1 |
| Mailman, RB; Negash, K; Nichols, DE; Watts, VJ | 1 |
| Chemel, BR; Cueva, JP; Giorgioni, G; Grubbs, RA; Nichols, DE; Watts, VJ | 1 |
| Cueva, JP; Gallardo-Godoy, A; Juncosa, JI; Lill, MA; Nichols, DE; Vidi, PA; Watts, VJ | 1 |
| Clark, AH; McCorvy, JD; Nichols, DE; Watts, VJ | 1 |
| Chemel, BR; Cueva, JP; Juncosa, JI; Lill, MA; Nichols, DE; Watts, VJ | 1 |
| Bekkam, M; Clark, AH; Conley, JM; McCorvy, JD; Nichols, DE; Watts, VJ; Williams, WK | 1 |
8 other study(ies) available for chlorpromazine and dihydrexidine
| Article | Year |
|---|---|
Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands.
Topics: Animals; Binding, Competitive; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Ligands; Male; Phenanthridines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship | 1995 |
9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Corpus Striatum; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Isoquinolines; Macaca mulatta; Male; Naphthols; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tumor Cells, Cultured | 1996 |
Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
Topics: Animals; Computer Simulation; Corpus Striatum; Dopamine Agonists; Indicators and Reagents; Models, Molecular; Molecular Conformation; Molecular Structure; Phenanthridines; Rats; Receptors, Dopamine D1; Software; Spiperone; Structure-Activity Relationship | 1997 |
trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
Topics: Animals; Benzopyrans; Binding, Competitive; Cell Line; Corpus Striatum; Crystallography, X-Ray; Cyclic AMP; Humans; In Vitro Techniques; Isoquinolines; Molecular Structure; Phenanthridines; Psychotropic Drugs; Radioligand Assay; Rats; Receptors, Dopamine D1; Stereoisomerism; Structure-Activity Relationship; Swine | 2006 |
Probing the steric space at the floor of the D1 dopamine receptor orthosteric binding domain: 7α-, 7β-, 8α-, and 8β-methyl substituted dihydrexidine analogues.
Topics: Binding Sites; Computer Simulation; Dopamine Agonists; Humans; Models, Molecular; Phenanthridines; Protein Binding; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 2011 |
Assessment of dopamine D₁ receptor affinity and efficacy of three tetracyclic conformationally-restricted analogs of SKF38393.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Binding, Competitive; Cells, Cultured; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Models, Molecular; Molecular Conformation; Receptors, Dopamine D1; Stereoisomerism; Structure-Activity Relationship | 2011 |
Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.
Topics: Animals; Corpus Striatum; Dopamine Agonists; Isoquinolines; Kinetics; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Phenanthridines; Receptors, Dopamine D1; Structure-Activity Relationship; Swine | 2012 |
Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand.
Topics: Binding, Competitive; Cells, Cultured; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Ligands; Models, Molecular; Molecular Conformation; Quinolines; Receptors, Dopamine D3; Structure-Activity Relationship | 2012 |